Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5655)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2013 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bär F, Sina C, Fellermann K. Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol 2013; 19(11): 1699-1706 [PMID: 23555158 DOI: 10.3748/wjg.v19.i11.1699] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i11/1699.htm |
| Number | Citing Articles |
| 1 |
K. Herrlinger, K. Fellermann, E.F. Stange. Therapie chronisch-entzündlicher Darmerkrankungen. Der Internist 2014; 55(8): 906 doi: 10.1007/s00108-013-3442-1
|
| 2 |
Ana Lúcia Sousa, Paulo Caldeira, Marta Eusébio, Alda Martins, Teresa Belo, Horácio Guerreiro. Azatioprina na doença inflamatória intestinal: fatores preditivos da resposta sustentada a longo prazo. GE Jornal Português de Gastrenterologia 2014; 21(4): 147 doi: 10.1016/j.jpg.2014.05.002
|
| 3 |
Oren Ledder, Daniel A Lemberg, Andrew S Day. Thiopurine-induced pancreatitis in inflammatory bowel diseases. Expert Review of Gastroenterology & Hepatology 2015; 9(4): 399 doi: 10.1586/17474124.2015.992879
|
| 4 |
Masahiro Iizuka, Takeshi Etou, Yosuke Shimodaira, Takashi Hatakeyama, Shiho Sagara. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis. World Journal of Gastroenterology 2021; 27(12): 1194-1212 doi: 10.3748/wjg.v27.i12.1194
|
| 5 |
Masahiro Iizuka, Takeshi Etou, Shiho Sagara. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy. World Journal of Gastroenterology 2022; 28(34): 4959-4972 doi: 10.3748/wjg.v28.i34.4959
|
| 6 |
Arvind I. Srinath, Neera Gupta, Sohail Z. Husain. Probing the Association of Pancreatitis in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(2): 465 doi: 10.1097/MIB.0000000000000611
|
| 7 |
X. Y. Qiu, M. J. Lu, H. J. Zhang. Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease—Authors' reply. Alimentary Pharmacology & Therapeutics 2018; 47(5): 690 doi: 10.1111/apt.14498
|
| 8 |
Ali ATAY, Yasemin ÖZDERİN ÖZİN, Dilara TURAN GÖKÇE, Müge BÜYÜKAKSOY, Gamze DEMİREL, Meral AKDOĞAN KAYHAN, Zeki Mesut Yalın KILIÇ, Emin ALTIPARMAK. İnflamatuvar bağırsak hastalığı olan hastalarda immünmodülatör tedaviler güvenli mi? 23 yıllık tek merkez deneyimi. Akademik Gastroenteroloji Dergisi 2023; 22(3): 142 doi: 10.17941/agd.1405423
|
| 9 |
Adriana Guerra Romero, José Lázaro Pérez Calle, Pilar López Serrano. Submaxilitis aguda secundaria a la toma de azatioprina en paciente con enfermedad de Crohn. Gastroenterología y Hepatología 2018; 41(9): 570 doi: 10.1016/j.gastrohep.2017.10.001
|
| 10 |
Rangnath Mishra, Punita Dhawan, Anand S Srivastava, Amar B Singh. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World Journal of Stem Cells 2020; 12(10): 1050-1066 doi: 10.4252/wjsc.v12.i10.1050
|
| 11 |
Adriana Guerra Romero, José Lázaro Pérez Calle, Pilar López Serrano. Azathioprine-induced acute submandibular sialadenitis in a patient with Crohn's disease. Gastroenterología y Hepatología (English Edition) 2018; 41(9): 570 doi: 10.1016/j.gastre.2018.11.001
|
| 12 |
Thomas Klag, Martin Goetz, Eduard F. Stange, Jan Wehkamp. Medical Therapy of Perianal Crohn's Disease. Visceral Medicine 2015; 31(4): 265 doi: 10.1159/000434664
|
| 13 |
Martin Kummen, Erik Schrumpf, Kirsten Muri Boberg. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology 2013; 27(4): 531 doi: 10.1016/j.bpg.2013.06.013
|
| 14 |
M. Raúl Acuña. Patología colorrectal. Revista Médica Clínica Las Condes 2014; 25(1): 114 doi: 10.1016/S0716-8640(14)70017-3
|
| 15 |
Najjia N. Mahmoud, Yasmin Halwani, Sandra de Montbrun, Puja M. Shah, Traci L. Hedrick, Farzana Rashid, David A. Schwartz, Robin L. Dalal, Jan P. Kamiński, Karen Zaghiyan, Phillip R. Fleshner, Jason M. Weissler, John P. Fischer. Current management of perianal Crohn’s disease. Current Problems in Surgery 2017; 54(5): 262 doi: 10.1067/j.cpsurg.2017.02.003
|
| 16 |
Katarína Maráková, Juraj Piešťanský, Peter Mikuš. Determination of Drugs for Crohn’s Disease Treatment in Pharmaceuticals by Capillary Electrophoresis Hyphenated with Tandem Mass Spectrometry. Chromatographia 2017; 80(4): 537 doi: 10.1007/s10337-016-3213-y
|
| 17 |
Masahiro Iizuka, Takeshi Etou, Makoto Kumagai, Atsushi Matsuoka, Yuka Numata, Shiho Sagara. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. Internal Medicine 2017; 56(20): 2705 doi: 10.2169/internalmedicine.8428-16
|
| 18 |
Marçal Pastor-Anglada, Sandra Pérez-Torras. Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. Frontiers in Pharmacology 2015; 6 doi: 10.3389/fphar.2015.00013
|
| 19 |
N. M. Heerasing, J. F. Ng, D. Dowling. Does lymphopenia or macrocytosis reflect 6‐thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6‐mercaptopurine?. Internal Medicine Journal 2016; 46(4): 465 doi: 10.1111/imj.12915
|
| 20 |
Salvatore Cucchiara, Marina Aloi. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2016; : 323 doi: 10.1007/978-3-319-17169-2_28
|
| 21 |
Kendra Kamp, Amanda Holmstrom, Zhehui Luo, Gwen Wyatt, Barbara Given. Factors Influencing Received Social Support Among Emerging Adults With Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(6): 429 doi: 10.1097/SGA.0000000000000483
|
| 22 |
Priyanka Moovara Cackamvalli, Faten Mohammed Abdullah Al Bakri, Izzat Ali M. Khanjar. Azathioprine induced acute sialadenitis: A case report. Clinical Case Reports 2023; 11(7) doi: 10.1002/ccr3.7662
|
| 23 |
Galen Leung, Marianna Papademetriou, Shannon Chang, Francis Arena, Seymour Katz. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy. Current Treatment Options in Gastroenterology 2016; 14(4): 507 doi: 10.1007/s11938-016-0109-8
|
| 24 |
Katarína Maráková, Juraj Piešťanský, Zuzana Zelinková, Peter Mikuš. Capillary Electrophoresis Hyphenated with Mass Spectrometry for Determination of Inflammatory Bowel Disease Drugs in Clinical Urine Samples. Molecules 2017; 22(11): 1973 doi: 10.3390/molecules22111973
|
| 25 |
Carole Rouiller-Braunschweig, Nicolas Fournier, Valérie Pittet, Jean Dudler, Pierre Michetti. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients. Digestion 2017; 96(4): 220 doi: 10.1159/000482007
|
| 26 |
Arvind Srinath, Erin Young, Eva Szigethy. Pain Management in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(12): 2433 doi: 10.1097/MIB.0000000000000170
|
| 27 |
Fatih Karaahmet, Hakan Akinci, Rasit Ayte, Mevlut Hamamci, Yusuf Coskun, Ilhami Yuksel. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's disease. Journal of Crohn's and Colitis 2013; 7(9): e404 doi: 10.1016/j.crohns.2013.04.010
|
| 28 |
Yueying Chen, Jun Shen. Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review. eClinicalMedicine 2022; 46: 101382 doi: 10.1016/j.eclinm.2022.101382
|
| 29 |
Axel Dignass, Ayesha Akbar, Ailsa Hart, Sreedhar Subramanian, Gilles Bommelaer, Daniel C. Baumgart, Jean-Charles Grimaud, Guillaume Cadiot, Richard Makins, Syed Hoque, Guillaume Bouguen, Bruno Bonaz. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results. Journal of Crohn's and Colitis 2016; 10(7): 812 doi: 10.1093/ecco-jcc/jjw032
|
| 30 |
Colin B. Peirce, Matthew F. Kalady. Fundamentals of Anorectal Surgery. 2019; : 531 doi: 10.1007/978-3-319-65966-4_29
|
| 31 |
Marta Freitas, Tiago Lima Capela, Vítor Macedo Silva, Cátia Arieira, Tiago Cúrdia Gonçalves, Francisca Dias de Castro, Maria João Moreira, João Firmino-Machado, José Cotter. Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease. Pancreas 2022; 51(3): 288 doi: 10.1097/MPA.0000000000002012
|
| 32 |
Ramya Movva, Alison Haywood, Sohil A Khan, Timothy HJ Florin, Iulia Oancea. Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?. Journal of Digestive Diseases 2017; 18(9): 529 doi: 10.1111/1751-2980.12536
|
| 33 |
Anita Annaházi, Tamás Molnár. Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/832395
|
| 34 |
Chi-Chun Ho, Wai-Ying Fong, Yuen-Hon Lee, Wing-Tat Poon. Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians. Genes 2017; 8(10): 285 doi: 10.3390/genes8100285
|
| 35 |
Nicholas M. Ruel, Khanh H. Nguyen, Gonzalo Vilas, James R. Hammond. Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase Transporter. Molecular Pharmacology 2019; 95(6): 584 doi: 10.1124/mol.118.114389
|
| 36 |
Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang. Comparison of <i>TPMT</i> and <i>NUDT15</i> polymorphisms in Chinese patients with inflammatory bowel disease. World Journal of Gastroenterology 2018; 24(8): 941-948 doi: 10.3748/wjg.v24.i8.941
|
| 37 |
Nicholas V. Costrini. Clearing of the Clouds in Inflammatory Bowel Disease Management. Digestive Diseases and Sciences 2020; 65(12): 3411 doi: 10.1007/s10620-020-06635-2
|
| 38 |
Younes El Gamrani, Khadija Krati. Les effets indésirables des thiopurines au cours du traitement d’entretien de la maladie de Crohn. Hegel 2017; (2): 107 doi: 10.3917/heg.072.0107
|
| 39 |
M.A. Payeras Capó, A. Escarda Gelabert, A. Erimeiku Barahona, I. Pérez Medrano, E. Antón Valentí, D. Ginard Vicens. Hiperplasia nodular regenerativa: hepatotoxicidad por 6-mercaptopurina en un paciente con enfermedad de Crohn. Enfermedad Inflamatoria Intestinal al Día 2017; 16(2): 84 doi: 10.1016/j.eii.2016.12.008
|